ResearchMoz presents professional and in-depth study of "Antimicrobial Susceptibility Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025".
Antimicrobial resistance is the ability of microorganisms to resist effects of a wide range of antimicrobial drugs. This condition leads to the ineffectiveness of standard treatments against microbial infections, persistence of infectious diseases, and their spread to others. It may require costly and toxic treatments.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377938
Antimicrobial resistance is one of the major challenges faced by health care professionals in recent years. Several clinical studies are under development for optimizing the therapeutic management of patients with infections. Antimicrobial susceptibility tests are conducted to detect the possible drug resistance by known microorganisms and to find out the most sensitive antimicrobial drug against the infective microorganism. Results of these tests help doctors optimize the therapeutic management of patients with infections. Different antimicrobial susceptibility tests and products have been developed including disk diffusion method, broth microdilution method, and rapid automated instrument method. Some of these methods yield qualitative results such as minimum inhibitory concentration (MIC), while others provide the qualitative information in three different categories: susceptible, intermediate, and resistant.
Increased usage of antibiotics in the treatment of microbial infections without proper indication and need is one of the most important reasons for development of antimicrobial resistance across the world. Emergence of several microorganisms resistant to antimicrobial drugs and high incidence rate of antimicrobial-resistant infections such as persistent sore throat, recurring urinary tract infection (UTI), and unresponsive case of pneumonia are some of the key factors driving the global antimicrobial susceptibility testing market. It has been observed that more than 50% of antibiotics are not optimally prescribed; sometimes they are prescribed when not needed. Also, spread of resistant strains of bacteria from person to person and from non-human sources into food, water, and natural environment increases the risk of antimicrobial resistance of pathogens. Development of automated testing equipment and newer tests and methods for detection of antimicrobial susceptibility would propel the antimicrobial susceptibility testing market during the forecast period. Automated testing equipment require a large number of viable organisms; they have limited organism spectrum; and they are quite costlier. This restricts the antimicrobial susceptibility testing market.
Make An Enquiry about TOC with tables & Figures @ https://www.researchmoz.us/enquiry.php?type=E&repid=1377938
The global antimicrobial susceptibility testing market can be segmented on the basis of method, product, test type, end-user, and region. Based on method, the market has been segmented into broth microdilution method, rapid automated instrument method, disk diffusion method, and gradient diffusion method. The rapid automated instrument method segment dominated the market in 2016 and is likely to account for a leading market share by 2025. Based on test type, the market has been divided into qualitative and quantitative tests. Based on product, the market has been classified into tests & kits, culture mediums, and automated test systems. End-users of antimicrobial susceptibility tests include biotechnology & pharmaceutical companies, hospitals & diagnostics centers, veterinary clinics, clinical research laboratories, and academic & research institutes.
In terms of geography, the global antimicrobial susceptibility testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for a major market share and is likely to hold a leading market share by 2025 as well. Europe follows North America, holding the second-largest share of the global market. The market in Europe is projected to be growing rapidly during the forecast period. High R&D expenditure by governments as well as private players, emergence of newer antimicrobial-resistant pathogens, and high incidence rate of antimicrobial resistance in the region are key factors estimated to drive the market in Europe during the forecast period.
Key players operating in the global antimicrobial susceptible testing market are bioMérieux, Inc., Bio-Rad Laboratories, Inc., HiMedia Laboratories, Thermo Fisher Scientific Inc., Laboratorios CONDA, S.A., Creative Diagnostics, Alifax S.r.l., Becton, Dickinson and Company, and Beckman Coulter, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
Browse Report @ https://www.researchmoz.us/antimicrobial-susceptibility-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
Antimicrobial resistance is the ability of microorganisms to resist effects of a wide range of antimicrobial drugs. This condition leads to the ineffectiveness of standard treatments against microbial infections, persistence of infectious diseases, and their spread to others. It may require costly and toxic treatments.
Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377938
Antimicrobial resistance is one of the major challenges faced by health care professionals in recent years. Several clinical studies are under development for optimizing the therapeutic management of patients with infections. Antimicrobial susceptibility tests are conducted to detect the possible drug resistance by known microorganisms and to find out the most sensitive antimicrobial drug against the infective microorganism. Results of these tests help doctors optimize the therapeutic management of patients with infections. Different antimicrobial susceptibility tests and products have been developed including disk diffusion method, broth microdilution method, and rapid automated instrument method. Some of these methods yield qualitative results such as minimum inhibitory concentration (MIC), while others provide the qualitative information in three different categories: susceptible, intermediate, and resistant.
Increased usage of antibiotics in the treatment of microbial infections without proper indication and need is one of the most important reasons for development of antimicrobial resistance across the world. Emergence of several microorganisms resistant to antimicrobial drugs and high incidence rate of antimicrobial-resistant infections such as persistent sore throat, recurring urinary tract infection (UTI), and unresponsive case of pneumonia are some of the key factors driving the global antimicrobial susceptibility testing market. It has been observed that more than 50% of antibiotics are not optimally prescribed; sometimes they are prescribed when not needed. Also, spread of resistant strains of bacteria from person to person and from non-human sources into food, water, and natural environment increases the risk of antimicrobial resistance of pathogens. Development of automated testing equipment and newer tests and methods for detection of antimicrobial susceptibility would propel the antimicrobial susceptibility testing market during the forecast period. Automated testing equipment require a large number of viable organisms; they have limited organism spectrum; and they are quite costlier. This restricts the antimicrobial susceptibility testing market.
Make An Enquiry about TOC with tables & Figures @ https://www.researchmoz.us/enquiry.php?type=E&repid=1377938
The global antimicrobial susceptibility testing market can be segmented on the basis of method, product, test type, end-user, and region. Based on method, the market has been segmented into broth microdilution method, rapid automated instrument method, disk diffusion method, and gradient diffusion method. The rapid automated instrument method segment dominated the market in 2016 and is likely to account for a leading market share by 2025. Based on test type, the market has been divided into qualitative and quantitative tests. Based on product, the market has been classified into tests & kits, culture mediums, and automated test systems. End-users of antimicrobial susceptibility tests include biotechnology & pharmaceutical companies, hospitals & diagnostics centers, veterinary clinics, clinical research laboratories, and academic & research institutes.
In terms of geography, the global antimicrobial susceptibility testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for a major market share and is likely to hold a leading market share by 2025 as well. Europe follows North America, holding the second-largest share of the global market. The market in Europe is projected to be growing rapidly during the forecast period. High R&D expenditure by governments as well as private players, emergence of newer antimicrobial-resistant pathogens, and high incidence rate of antimicrobial resistance in the region are key factors estimated to drive the market in Europe during the forecast period.
Key players operating in the global antimicrobial susceptible testing market are bioMérieux, Inc., Bio-Rad Laboratories, Inc., HiMedia Laboratories, Thermo Fisher Scientific Inc., Laboratorios CONDA, S.A., Creative Diagnostics, Alifax S.r.l., Becton, Dickinson and Company, and Beckman Coulter, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
Market segments and sub-segments
Market trends and dynamics
Supply and demand
Market size
Current trends/opportunities/challenges
Competitive landscape
Technological breakthroughs
Value chain and stakeholder analysis
Browse Report @ https://www.researchmoz.us/antimicrobial-susceptibility-testing-market-global-industry-analysis-size-share-growth-trends-and-forecast-2017-2025-report.html
The regional analysis covers:
North America (U.S. and Canada)
Latin America (Mexico, Brazil, Peru, Chile, and others)
Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
Eastern Europe (Poland and Russia)
Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
Middle East and Africa (GCC, Southern Africa, and North Africa)
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow me on : https://marketinfo247.wordpress.com/
No comments:
Post a Comment